Herman Talmadge Palmer, MD | |
529 S Fourth St, Baldwyn, MS 38824-2114 | |
(662) 365-2222 | |
Not Available |
Full Name | Herman Talmadge Palmer |
---|---|
Gender | Male |
Speciality | |
Experience | Years |
Location | 529 S Fourth St, Baldwyn, Mississippi |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1811088115 | NPI | - | NPPES |
00113358 | Medicaid | MS |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208D00000X | General Practice | 09648 (Mississippi) | Primary |
Mailing Address | Practice Location Address |
---|---|
Herman Talmadge Palmer, MD 529 S Fourth St, Baldwyn, MS 38824-2114 Ph: (662) 365-2222 | Herman Talmadge Palmer, MD 529 S Fourth St, Baldwyn, MS 38824-2114 Ph: (662) 365-2222 |
News Archive
Jennifer J. Lentz, PhD, Associate Professor at LSU Health New Orleans Neuroscience Center of Excellence and Departments of Otorhinolaryngology, Genetics and Ophthalmology, in collaboration with Robert K. Koenekoop MD, PhD and Professor of Pediatric Surgery, Human Genetics and Ophthalmology at McGill University in Montreal, Quebec, Canada, has been awarded a $1.74 million USD grant to advance research on Usher syndrome.
Children exposed to coarse particulate matter may be more likely to develop asthma and to be treated in an ER or be hospitalized for the condition, according to new research published online in the American Thoracic Society's American Journal of Respiratory and Critical Care Medicine.
The University of Liverpool, Liverpool School of Tropical Medicine and Southampton Clinical Trials Unit announced this week that they have launched their innovative COVID-19 drug testing platform, AGILE.
Vanda Pharmaceuticals Inc. announced today that the U.S. Patent and Trademark Office has issued a notice of allowance for its patent application of a microsphere, long-acting injectable formulation of its antipsychotic product, Fanaptâ„¢ (iloperidone). When issued, this U.S. patent will expire on October 30, 2022, and in addition, the U.S. Patent and Trademark Office has granted a patent term adjustment of 300 days, leading to an effective expiration date of August 26, 2023.
Cleveland Clinic Children's will host its second annual Pediatric Innovation Summit June 11 to 13, 2015, at the Global Center for Health Innovation in Cleveland. Designed to promote the professional development of physicians and healthcare providers, the event will explore the current state of pediatric care and the cutting-edge medical advancements transforming the research and treatment of childhood diseases.
› Verified 8 days ago